Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

277.09 -25.36 (-8.38%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
Topics Government
Humana 2025 Outlook Shows Cautious Optimism Despite Industry Pressures
Humana reported a Q4 adjusted EPS loss of $2.16 while revenue grew 13.5% year-over-year to $29.19 billion. 
Via Benzinga
Alphabet's Verily Sells Granular Insurance To Elevance Health Amid Healthcare Strategy Refocus
Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, Granular Insurance Company, to Elevance Health. 
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
Via Benzinga
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
A Glimpse Into The Expert Outlook On Elevance Health Through 6 Analysts
Via Benzinga
Elevance Health Dividend Increase
On 23 January, Elevance Health (ELV) increased its quarterly dividend by 4.91%, from $1.63 to $1.71 per share. The dividend is payable on 25 March to shareholders of record on 10 March. 
Via Talk Markets
Topics Stocks / Equities
How Is The Market Feeling About Elevance Health?
Via Benzinga
Top S&P500 movers in Monday's session
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was... 
Via StockStory
5 Stocks With Above-Market Yields Just Raised Payments Further
These five stocks with dividend yields already eclipsing that of the overall market just pushed their quarterly dividend payments higher. 
Via MarketBeat
Topics ETFs Government
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people. 
Via Benzinga
Topics Government
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. 
Via MarketBeat
Topics Artificial Intelligence
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected. 
Via Stocktwits
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared. 
Via Benzinga
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
From Elevance Health, Inc.
Via Business Wire
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Many stocks flashed buy signals as the major indexes rose to or above key levels. 
Via Investor's Business Daily
Topics Economy
Here's How Much $100 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Via Benzinga
Earnings Scheduled For January 23, 2025
Via Benzinga
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's... 
Via Benzinga
A Closer Look at Elevance Health's Options Market Dynamics
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Via Benzinga
Peering Into Elevance Health's Recent Short Interest
Via Benzinga
UnitedHealth Earnings Beat But Soft Revenue, Higher Costs Hit UNH Stock
The Dow giant earnings beat Q4 views, but revenue missed and medical costs ran high. 
Via Investor's Business Daily
Topics Earnings Stocks
Visualizing America’s $1.7 Trillion Insurance Industry
As of Jan. 7, 2025, UnitedHealth Group is the country’s most valuable insurance company, with a market cap of $473 billion. 
Via Talk Markets
Topics Stocks / Equities
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
From Elevance Health, Inc.
Via Business Wire
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
HCA Healthcare: 4 Reasons to Buy the 25% Dip
Discover why HCA Healthcare stock could be poised for a recovery despite recent setbacks, including hurricane-related expenses and claim denials. 
Via MarketBeat
Topics Government
Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders
From Robbins LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.